title: Ibrutinib-associated tumor lysis syndrome in a patient with chronic lymphocytic leukemia.
authors.affiliation: Division of Hematology/Oncology, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR.
authors.forename: Varinder
authors.initials: V
authors.lastname: Kaur
authors.affiliation: Division of Hematology/Oncology, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR.
authors.forename: Paulette
authors.initials: P
authors.lastname: Mehta
authors.affiliation: Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR.
authors.forename: Joyce
authors.initials: J
authors.lastname: Johnsurd
authors.affiliation: Division of Hematology/Oncology, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR.
authors.forename: Rangaswamy
authors.initials: R
authors.lastname: Govindarajan
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D010880:Piperidines; D011720:Pyrazoles / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*; D015275:Tumor Lysis Syndrome / Q000175:diagnosis / Q000209:etiology*
chemical_list: D010880:Piperidines; D011720:Pyrazoles; D011743:Pyrimidines; C551803:ibrutinib; D000225:Adenine